サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1609559

トリプシンの市場規模、シェア、動向分析レポート：供給源別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

Trypsin Market Size, Share & Trends Analysis Report By Source (Bovine, Porcine), By Application (Biotechnology & Pharmaceutical Industry, Food Industry), By End-use (Research, Diagnostic, Industrial Use), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
トリプシンの市場規模、シェア、動向分析レポート：供給源別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年
出版日: 2024年11月07日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

トリプシン市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のトリプシン市場規模は2025～2030年にかけて5.4%のCAGRを記録し、2030年には1,315億米ドルに達すると推定されています。

医薬品、食品科学研究、洗剤、皮革加工など、さまざまな産業でトリプシンの採用が増加していることが、市場成長の原動力になりそうです。がん、急性膵炎、吸収不良、嚢胞性線維症などの幅広い疾患の診断におけるトリプシンの可能性を評価するために様々な調査研究が行われているほか、創薬や研究開発への注目も高まっており、市場の成長をさらに促進すると予想されます。

トリプシンは、タンパク質を加水分解するという特殊な消化機能により、製薬、食品、環境産業の研究開発で広く使用されています。トリプシンは、内分泌疾患や臨床外科における内服薬の原料として機能します。酵素触媒の使用は、製薬、飲食品、食品産業における商業プロセス用にスケールアップされています。これらの酵素は廃棄物の削減に役立つため、食品、医薬品、飼料産業で使用するのに非常に効率的です。さらに、トリプシンの最良の供給源であるTRYPSIN VIは、動物用と人間用の抗炎症治療や消化補助食品として栄養補助食品に利用されています。

がん、急性膵炎、吸収不良、嚢胞性線維症などの幅広い疾患の診断における可能性を評価するために、様々な調査が行われています。研究開発費の増加、新薬上市の増加、FDA承認。

トリプシン市場レポートハイライト

  • 供給源別では、臨床診断、研究、飲食品産業、食肉軟化のセグメントで顕著な用途があるため、ウシ部門が2024年に59.71%の最大収益シェアで市場をリードしました。
  • 供給源別では、ブタセグメントは予測期間中に著しいCAGRで成長すると予想されます。
  • 用途別では、バイオテクノロジー・製薬産業セグメントが2024年に56.40％の最大収益シェアで市場を占め、予測期間中最も速いCAGRが見込まれます。創薬と開発への注目の高まりが成長をさらに促進しています。
  • 北米は、様々ながんの有病率の増加、高い購買力平価、質の高い医療に対する政府の支援、償還の利用可能性などの要因により、2024年に40.49%の最大の売上高シェアで市場を独占しました。
  • 2023年12月、業務用酵素関連製品とサービスの世界的パイオニアであるCreative Enzymesは、トリプシン-キモトリプシンなどのタンパク質分解酵素の組み合わせ製品を発表しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 トリプシン市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/補助的な市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • トリプシン市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析

第4章 トリプシン市場： 供給源別、推定・動向分析

  • 世界のトリプシン：供給源ダッシュボード
  • 世界のトリプシン：供給源変動分析2024年と2030年
  • 世界のトリプシンの供給源別収益 2018～2030年
  • 2018～2030年の市場規模と予測と動向分析
  • ブタ
  • ウシ
  • その他

第5章 トリプシン市場：用途別、推定・動向分析

  • 世界のトリプシン：用途ダッシュボード
  • 世界のトリプシン：用途変動分析2024年と2030年
  • 世界のトリプシンの用途別収益 2018～2030年
  • 2018～2030年の市場規模と予測と動向分析
  • バイオテクノロジー・製薬産業
  • 食品産業
  • 化粧品・パーソナルケア
  • 廃棄物治療
  • その他

第6章 トリプシン市場：最終用途別、推定・動向分析

  • 世界のトリプシン：最終用途ダッシュボード
  • 世界のトリプシン：最終用途の変動分析2024年と2030年
  • 世界のトリプシンの最終用途別収益 2018～2030年
  • 2018～2030年の市場規模と予測と動向分析
  • 研究
  • 診断
  • 工業用途

第7章 トリプシン市場：地域別、推定・動向分析

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 世界地域市場のスナップショット
  • 市場規模、予測動向分析、2018～2030年
  • 北米
    • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • 主要販売代理店とチャネルパートナー一覧
    • 主要企業の市場シェア分析、2024年
    • Thermo Fisher Scientific, Inc
    • Promega Corporation
    • Merck Millipore
    • Novozymes
    • Sartorius AG
    • Neova Technologies
    • BIOZYM
    • Bovogen Biologicals
    • Zymetech
    • BBI Solutions
    • Linzyme Biosciences
    • PromoCell GmbH
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Trypsin market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 4 North America Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 7 U.S. Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 10 Canada Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Mexico Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 13 Mexico Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 14 Mexico Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe Trypsin market, by region, 2018 - 2030 (USD Million)
  • Table 16 Europe Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 17 Europe Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 18 Europe Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Germany Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 20 Germany Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 21 Germany Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 22 UK Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 23 UK Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 24 UK Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 25 France Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 26 France Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 27 France Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Italy Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 29 Italy Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 30 Italy Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Spain Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 32 Spain Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 33 Spain Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Denmark Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 35 Denmark Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 36 Denmark Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Sweden Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 38 Sweden Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 39 Sweden Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Norway Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 41 Norway Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 42 Norway Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Trypsin market, by region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 47 China Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 48 China Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 49 China Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Japan Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 51 Japan Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 52 Japan Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 53 India Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 54 India Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 55 India Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 56 South Korea Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 57 South Korea Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Australia Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 60 Australia Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 61 Australia Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Thailand Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 63 Thailand Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 64 Thailand Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 66 Latin America Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 67 Latin America Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Brazil Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 69 Brazil Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 70 Brazil Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 71 Argentina Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 72 Argentina Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 73 Argentina Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 74 MEA Trypsin market, by region, 2018 - 2030 (USD Million)
  • Table 75 MEA Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 76 MEA Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 77 MEA Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 78 South Africa Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 79 South Africa Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 80 South Africa Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 84 UAE Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 85 UAE Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 86 UAE Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 87 Kuwait Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Trypsin market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Trypsin market: market outlook
  • Fig. 14 Trypsin competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook.
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Trypsin market driver impact
  • Fig. 20 Trypsin market restraint impact
  • Fig. 21 Trypsin market strategic initiatives analysis
  • Fig. 22 Trypsin market: Source movement analysis
  • Fig. 23 Trypsin market: Source outlook and key takeaways
  • Fig. 24 Bovine market estimates and forecasts, 2018 - 2030
  • Fig. 25 Porcine market estimates and forecasts,2018 - 2030
  • Fig. 26 Others market estimates and forecasts,2018 - 2030
  • Fig. 27 Trypsin market: Application movement analysis
  • Fig. 28 Trypsin market: Application outlook and key takeaways
  • Fig. 29 Biotechnology and Pharmaceutical Industry market estimates and forecast, 2018 - 2030
  • Fig. 30 Food Industry market estimates and forecast, 2018 - 2030
  • Fig. 31 Cosmetics and Personal Care market estimates and forecast, 2018 - 2030
  • Fig. 32 Waste Treatment market estimates and forecast, 2018 - 2030
  • Fig. 33 Others market estimates and forecast, 2018 - 2030
  • Fig. 34 Trypsin market: end use movement analysis
  • Fig. 35 Trypsin market: end use outlook and key takeaways
  • Fig. 36 Research Studies market estimates and forecasts, 2018 - 2030
  • Fig. 37 Diagnostics market estimates and forecasts,2018 - 2030
  • Fig. 38 Industrial use market estimates and forecasts, 2018 - 2030
  • Fig. 39 Global Trypsin market: Regional movement analysis
  • Fig. 40 North America market estimates and forecasts, 2018 - 2030
  • Fig. 41 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 42 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 43 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 44 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 45 UK market estimates and forecasts, 2018 - 2030
  • Fig. 46 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 47 France market estimates and forecasts, 2018 - 2030
  • Fig. 48 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 49 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 50 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 51 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 52 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 53 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 54 China market estimates and forecasts, 2018 - 2030
  • Fig. 55 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 56 India market estimates and forecasts, 2018 - 2030
  • Fig. 57 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 58 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 59 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 60 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 61 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 62 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 63 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 64 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 65 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 66 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 67 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 68 Market share of key market players - Trypsin market
目次
Product Code: GVR-4-68040-273-6

Trypsin Market Growth & Trends:

The global trypsin market size is estimated to reach USD 131.5 billion by 2030, registering a CAGR of 5.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing adoption of trypsin across various industries, such as pharmaceuticals, food science research, detergents, and leather-bating, is likely to drive the market growth. Where as various research studies are being conducted to evaluate its potential in diagnosing a wide range of disorders, such as cancer, acute pancreatitis, malabsorption, and cystic fibrosis, along with increasing focus on drug discovery and development is expected to further propel the market growth.

Trypsin is widely being used in R&D in pharmaceutical, food, and environmental industries, owing to its special digestive functions of hydrolyzing proteins. It acts as a raw material for internal medicine in endocrine diseases and clinical surgery. The use of enzyme catalysts has been scaled up for commercial processes in the pharmaceutical, beverages, and food industries. These enzymes help in waste reduction, which makes them highly efficient to be used in food, pharmaceuticals, and feed industries. Moreover, the best source of trypsin, TRYPSIN VI, has found nutraceutical use as an anti-inflammatory treatment and a digestive supplement for veterinary & human applications.

Various research studies are being conducted to evaluate its potential in diagnosing a wide range of disorders, such as cancer, acute pancreatitis, malabsorption, and cystic fibrosis. Increase in R&D expenditure, the rising drug launches, and FDA approvals.

Trypsin Market Report Highlights:

  • Based on source, the bovine segment led the market with the largest revenue share of 59.71% in 2024, owing to prominent application in field of clinical diagnostics, research, food and beverage industry and meat tenderization
  • Based on source, the porcine segment is expected to grow at the significant CAGR over the forecast period
  • Based on application, the biotechnology and pharmaceutical industry segment held the market with the largest revenue share of 56.40% in 2024, and is further anticipated to witness the fastest CAGR over the forecast period. The increasing focus on drug discovery and development is further propelling growth
  • North America dominated the market with the largest revenue share of 40.49% in 2024, owing to factors such as increasing the prevalence of various cancer, high purchasing power parity, government support for quality healthcare, and availability of reimbursement
  • In Dec 2023, Creative Enzymes, a global pioneer in professional enzyme related products and services unveiled its combination product offerings for proteolytic enzymes such as Trypsin-Chymotrypsin, with this company aims at optimizing the speed and efficiency of the digestive process opening new possibilities for medical and pharmaceutical enhancements.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1 Source
    • 1.2.2 Application
    • 1.2.3 end use
    • 1.2.4 Regional scope
    • 1.2.5 Estimates and forecasts timeline.
  • 1.3. Research methodology
  • 1.4. Information Procurement
    • 1.4.1 Purchased database
    • 1.4.2 GVR's internal database
    • 1.4.3 Secondary sources
    • 1.4.4 Primary research
    • 1.4.5 Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1 Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1 Commodity flow analysis (Model 1)
    • 1.7.2 Approach 1: Commodity flow approach
    • 1.7.3 Volume price analysis (Model 2)
    • 1.7.4 Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1 Source outlook
    • 2.2.2 Application outlook
    • 2.2.3 end use outlook
    • 2.2.4 Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Trypsin Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 1.3.1 Parent market outlook
    • 2.3.1 Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1 Market driver analysis
      • 3.2.1.1. Rising prevalence of gastrointestinal disorders
      • 3.2.1.2. Increasing trypsin related studies and therapeutics
      • 3.2.1.3. Technological advancements
    • 3.2.2 Market restraint analysis
      • 3.2.2.1. Stringent regulations
      • 3.2.2.2. High cost of sourcing
  • 3.3. Trypsin Market Analysis Tools
    • 3.3.1 Industry Analysis - Porter's
    • 3.3.1 PESTEL Analysis

Chapter 4. Trypsin Market: Source Estimates & Trend Analysis

  • 4.1. Global Trypsin: Source Dashboard
  • 4.2. Global Trypsin: Source Movement Analysis 2024 & 2030
  • 4.3. Global Trypsin by Source, Revenue 2018 - 2030 (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Porcine
    • 4.5.1 Porcine Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Bovine
    • 4.6.1 Bovine Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Others
    • 4.7.1 Others Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Trypsin Market: Application Estimates & Trend Analysis

  • 5.1. Global Trypsin: Application Dashboard
  • 5.2. Global Trypsin: Application Movement Analysis 2024 & 2030
  • 5.3. Global Trypsin by Application, Revenue 2018 - 2030 (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Biotechnology and Pharmaceutical Industry
    • 5.5.1 Biotechnology and Pharmaceutical Industry Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Food Industry
    • 5.6.1 Food Industry Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Cosmetics and Personal Care
    • 5.7.1 Cosmetics and Personal Care Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Waste Treatment
    • 5.8.1 Waste Treatment Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1 Others Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Trypsin Market: end use Estimates & Trend Analysis

  • 6.1. Global Trypsin: end use Dashboard
  • 6.2. Global Trypsin: end use Movement Analysis 2024 & 2030
  • 6.3. Global Trypsin by end use, Revenue 2018 - 2030 (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Research
    • 6.5.1 Research Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Diagnostics
    • 6.6.1 Diagnostics Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Industrial use
    • 6.7.1 Industrial use Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Trypsin Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1 North America
    • 7.5.2 U.S.
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3 Canada
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4 Mexico
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1 Europe
    • 7.6.2 UK
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3 Germany
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4 France
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5 Italy
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6 Spain
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7 Norway
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8 Sweden
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.9 Denmark
      • 7.6.9.1. Key country dynamics
      • 7.6.9.2. Regulatory framework
      • 7.6.9.3. Competitive scenario
      • 7.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1 Asia Pacific
    • 7.7.2 Japan
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3 China
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4 India
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5 Australia
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6 South Korea
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.7 Thailand
      • 7.7.7.1. Key country dynamics
      • 7.7.7.2. Regulatory framework
      • 7.7.7.3. Competitive scenario
      • 7.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1 Latin America
    • 7.8.2 Brazil
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3 Argentina
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1 MEA
    • 7.9.2 South Africa
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3 Saudi Arabia
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4 UAE
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.5 Kuwait
      • 7.9.5.1. Key country dynamics
      • 7.9.5.2. Regulatory framework
      • 7.9.5.3. Competitive scenario
      • 7.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1 List of key distributors and channel partners
    • 8.3.2 Key customers
    • 8.3.3 Key company market share analysis, 2024
    • 8.3.4 Thermo Fisher Scientific, Inc
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Source benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5 Promega Corporation
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Source benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6 Merck Millipore
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Source benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7 Novozymes
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Source benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8 Sartorius AG
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Source benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Neova Technologies
      • 8.3.9.6. Company overview
      • 8.3.9.7. Financial performance
      • 8.3.9.8. Source benchmarking
      • 8.3.9.9. Strategic initiatives
    • 8.3.10 BIOZYM
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Source benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11 Bovogen Biologicals
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Source benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12 Zymetech
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Source benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13 BBI Solutions
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Source benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14 Linzyme Biosciences
      • 8.3.14.1. Company Overview
      • 8.3.14.2. Financial Performance
      • 8.3.14.3. Source Benchmarking
      • 8.3.14.4. Strategic Initiatives
    • 8.3.15 PromoCell GmbH.
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial Performance
      • 8.3.15.3. Source Benchmarking
      • 8.3.15.4. Strategic Initiatives